Following the exit of a Canadian producer of key medical radioisotope molybdenum-99 (Mo-99), South African company NTP Radioisotopes has stepped into the supply gap and increased its global market share. The global nuclear medicine market, which includes radioisotopes and medical equipment, was valued at over US$11-billion in 2016, and is now projected to reach nearly US$20-billion by 2021. Nuclear medicine uses tiny amounts of radioactive isotopes (radioisotopes), mostly for medical ...
Please enter the email address that you used to subscribe to Research Channel. Your password will be sent to this address.
Don't have any login details?
Free Trial Access